Circulating endothelin-1 levels in type 2 diabetic patients with ischaemic heart disease. 1996

M Donatelli, and E Hoffmann, and I Colletti, and G Andolina, and V Russo, and M L Bucalo, and T M Valenti, and V Compagno, and M G Cataldo, and M L Morici
Institute of Medical Clinic, University of Palermo, Italy.

To investigate whether circulating endothelin-1 (Et-1) may be related to the increased incidence and severity of ischaemic heart disease in type 2 diabetes mellitus, we compared the concentrations in type 2 diabetic patients and in non-diabetic patients with coronary artery disease (CAD) angiographically documented. Plasma levels of Et-1 were determined in 34 type 2 diabetic patients with CAD (16 with stable angina, 6 with unstable angina, 12 with previous myocardial infarction) and in 19 nondiabetic patients with CAD (4 with stable angina, 5 with unstable angina, 10 with previous myocardial infarction). Fifteen diabetic patients without CAD and 9 healthy volunteers served as control subjects. In the type 2 diabetic patients, the mean Et-1 levels were 3.19 +/- 1.61 pmol/l in those with stable angina, 3.58 +/- 1.92 pmol/l in those with unstable angina, 4.24 +/- 2.53 pmol/l in those with myocardial infarction. These values were not significantly different one another, nor from the values obtained from type 2 diabetic controls (3.64 +/- 2.13 pmol/l). In the non-diabetic patients, the mean Et-1 levels were 3.92 +/- 0.73 pmol/l in those with stable angina, 4.35 +/- 1.67 pmol/l in those with unstable angina, 4.33 +/- 1.66 pmol/l in those with myocardial infarction. These values were not significantly different one another, but significantly higher than those obtained from healthy controls (2.07 +/- 0.67 pmol/l; P < 0.001). No significant differences were found in Et-1 levels between diabetic and non-diabetic patients with stable, unstable angina and previous myocardial infarction. In contrast, a statistically significant difference was found in Et-1 levels between diabetic and non-diabetic control subjects (P < 0.05). In conclusion, similar raised concentrations of Et-1 in diabetic and non-diabetic patients with stable, unstable angina and previous myocardial infarction do not support the hypothesis that higher levels of Et-1 in diabetic patients are responsible for the increased incidence of CAD in diabetes mellitus. However, the raised Et-1 levels found in diabetic patients in the absence of CAD strongly suggest that a generalised endothelial dysfunction, documented in our study by increased levels of Et-1, most probably precedes subsequent cardiovascular diseases.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000704 Analysis of Variance A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable. ANOVA,Analysis, Variance,Variance Analysis,Analyses, Variance,Variance Analyses

Related Publications

M Donatelli, and E Hoffmann, and I Colletti, and G Andolina, and V Russo, and M L Bucalo, and T M Valenti, and V Compagno, and M G Cataldo, and M L Morici
December 1995, Acta diabetologica,
M Donatelli, and E Hoffmann, and I Colletti, and G Andolina, and V Russo, and M L Bucalo, and T M Valenti, and V Compagno, and M G Cataldo, and M L Morici
October 1994, Annals of allergy,
M Donatelli, and E Hoffmann, and I Colletti, and G Andolina, and V Russo, and M L Bucalo, and T M Valenti, and V Compagno, and M G Cataldo, and M L Morici
January 2015, Diabetology & metabolic syndrome,
M Donatelli, and E Hoffmann, and I Colletti, and G Andolina, and V Russo, and M L Bucalo, and T M Valenti, and V Compagno, and M G Cataldo, and M L Morici
October 2005, Diabetic medicine : a journal of the British Diabetic Association,
M Donatelli, and E Hoffmann, and I Colletti, and G Andolina, and V Russo, and M L Bucalo, and T M Valenti, and V Compagno, and M G Cataldo, and M L Morici
October 2021, Pathophysiology : the official journal of the International Society for Pathophysiology,
M Donatelli, and E Hoffmann, and I Colletti, and G Andolina, and V Russo, and M L Bucalo, and T M Valenti, and V Compagno, and M G Cataldo, and M L Morici
January 2002, Journal of biological regulators and homeostatic agents,
M Donatelli, and E Hoffmann, and I Colletti, and G Andolina, and V Russo, and M L Bucalo, and T M Valenti, and V Compagno, and M G Cataldo, and M L Morici
October 2011, Diabetic medicine : a journal of the British Diabetic Association,
M Donatelli, and E Hoffmann, and I Colletti, and G Andolina, and V Russo, and M L Bucalo, and T M Valenti, and V Compagno, and M G Cataldo, and M L Morici
May 2008, Diabetes research and clinical practice,
M Donatelli, and E Hoffmann, and I Colletti, and G Andolina, and V Russo, and M L Bucalo, and T M Valenti, and V Compagno, and M G Cataldo, and M L Morici
May 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme,
M Donatelli, and E Hoffmann, and I Colletti, and G Andolina, and V Russo, and M L Bucalo, and T M Valenti, and V Compagno, and M G Cataldo, and M L Morici
July 2000, Ugeskrift for laeger,
Copied contents to your clipboard!